Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.

Abstract

OBJECTIVE To test the hypothesis that the selective serotonin reuptake inhibitor (SSRI) citalopram would down-regulate human immunodeficiency virus (HIV) infectivity and that the greatest effects would be seen in people with depression. Depression is a risk factor for morbidity and mortality in HIV/acquired immune deficiency syndrome. Serotonin (5-HT… (More)
DOI: 10.1097/PSY.0b013e3181f883ce

Topics

  • Presentations referencing similar topics